Supplemental material
OncoImmunology
Volume 12, 2023 - Issue 1
Open access
2,081
Views
1
CrossRef citations to date
0
Altmetric
Original Research
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
Xin Jina School of Medicine, Nankai University, Tianjin, China;b Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China;c Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaCorrespondence[email protected]
View further author information
, View further author information
Danni Xied First Central Clinical College, Tianjin Medical University, Tianjin, ChinaView further author information
, Rui Suna School of Medicine, Nankai University, Tianjin, ChinaView further author information
, Wenyi Luc Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaView further author information
, Xia Xiaoc Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaView further author information
, Yibing Yud First Central Clinical College, Tianjin Medical University, Tianjin, ChinaView further author information
, Juanxia Mengc Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaView further author information
& Mingfeng Zhaoc Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 2248826
|
Received 12 Mar 2023, Accepted 14 Aug 2023, Published online: 26 Aug 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.